id,sentences,label,sentences_tokens,cuis
0,"116 ||| ACKNOWLEDGMENTS ||| 5.4 ||| Chul Joong Lee was responsible for the conception, design, interpretation of data, drafting, revising and final approval of the article.",N,chul joong lee responsible conception design interpretation data drafting revising final approval article,G0000000|G0000000|G0000000|C1273518|C0009637|C1707689|C0459471|C1511726|C1547277|C1527075|C0205088|C0205540|C1706852
1,22 ||| PATIENTS AND METHODS ||| 1.6 ||| Patients with a history of hypertension were included in the study only if confirmed to be of medically well-controlled status with blood pressure Ͻ140/90 mm Hg with or without anti-hypertensive medication.,P,patients history hypertension included study confirmed medically well-controlled status blood pressure 140/90 mm hg anti-hypertensive medication,C0030705|C0019664|C0020538|C0332257|C0557651|C0521093|G0000000|C3853142|C0449438|C0005767|C0033095|C1442061|G0000000|C0025424|C0003364|C0013227
2,"99 ||| DISCUSSION ||| 3.23 ||| Because the literature reports a hydromorphone-to-morphine equianalgesic potency of 1:5 to 1:7, 12,13 a conversion ratio of 1:7 was used to select 0.03 mg/kg of hydromorphone.",O,literature reports hydromorphone-to-morphine equianalgesic potency 1 5 1 7 12 13 conversion ratio 1 7 select 0 03 mg/kg hydromorphone,C0023866|C0684224|C0012306|G0000000|C3245505|G0000000|G0000000|G0000000|G0000000|C0450371|C0450371|C0439836|C0456603|G0000000|G0000000|C1707391|G0000000|C0450371|C0439272|C0012306
3,14 |||  ||| 0.14 ||| Opioid receptors are known to be present in peripheral sensory nerve terminals as well as in the dorsal root ganglion and the central terminal of primary afferent nerves.,N,opioid receptors peripheral sensory nerve terminals dorsal root ganglion central terminal primary afferent nerves,C0242402|C0597357|C0205100|C0445254|C0027740|C0205088|C0205095|C0040452|C0017067|C0205099|C0205088|C0205225|C0205115|C0027740
4,"107 ||| DISCUSSION ||| 3.31 ||| Although withdrawal movement occurred significantly more in patients in the saline group, it did not cause severe adverse outcomes such as loss of intravenous cannulation, prolongation of intubation time, or loss of correct endotracheal tube placement.",I,withdrawal movement occurred patients saline severe adverse outcomes loss intravenous cannulation prolongation intubation time loss correct endotracheal tube placement,C2349954|C0026649|C1709305|C0030705|C0036082|C0205082|G0000000|C1274040|C1517945|C0348016|C0917707|C0439590|C0021925|C0040223|C1517945|C2349182|C0599554|C0175730|C0441587
5,"121 ||| ACKNOWLEDGMENTS ||| 5.9 ||| Woo Seog Sim was responsible for the conception, design, interpretation of data, drafting, revising and final approval of the article.",N,woo seog sim responsible conception design interpretation data drafting revising final approval article,G0000000|G0000000|C1420068|C1273518|C0009637|C1707689|C0459471|C1511726|C1547277|C1527075|C0205088|C0205540|C1706852
6,"8 |||  ||| 0.8 ||| After loss of consciousness, rocuronium 0.6 mg/kg was injected and immediate withdrawal movements were recorded.",I,loss consciousness rocuronium 0 6 mg/kg injected withdrawal movements recorded,C1517945|C0009791|C0209337|G0000000|G0000000|C0439272|C1720154|C2349954|C0026649|C0034869
7,"52 ||| Statistical Analysis ||| 2.3 ||| Patient characteristics and intravenous cannulation sites were compared using ␹ 2 test, Fisher exact test, Kruskal-Wallis test, or 1-way ANOVA where appropriate.",N,patient characteristics intravenous cannulation sites compared 2 test fisher exact test kruskal-wallis test 1-way anova,C0030705|C1521970|C0348016|C0917707|C0205145|C1707455|G0000000|C0022885|C0325045|C2828393|C0022885|G0000000|C0022885|G0000000|G0000000
8,31 ||| PATIENTS AND METHODS ||| 1.15 ||| Premedication was not administered before surgery.,N,premedication administered surgery,C0033045|C1521801|C0038894
9,"101 ||| DISCUSSION ||| 3.25 ||| Second, the duration of hemodynamic monitoring was not long enough to fully evaluate the effects of hydromorphone on hemodynamic stability.",N,duration hemodynamic monitoring evaluate effects hydromorphone hemodynamic stability,C0449238|C0019010|C0150369|C0220825|C1280500|C0012306|C0019010|C0205360
10,27 ||| PATIENTS AND METHODS ||| 1.11 ||| The anesthesiologist (S.Y.L.,N,anesthesiologist,C0334910
11,104 ||| DISCUSSION ||| 3.28 ||| This study was designed deliberately to turn sevoflurane on after rocuronium injection to rule out any potential confounding effect of sevoflurane on withdrawal movements.,I,study designed deliberately sevoflurane rocuronium injection rule potential confounding sevoflurane withdrawal movements,C0557651|C1707689|G0000000|C0074414|C0209337|C0021485|C0805874|C3245505|G0000000|C0074414|C2349954|C0026649
12,80 ||| DISCUSSION ||| 3.4 ||| The search did not identify any studies regarding the use of hydromorphone as an adjuvant agent for general anesthesia.,I,search identify studies hydromorphone adjuvant agent anesthesia,C1552603|G0000000|C0947630|C0012306|C0001551|C0450442|C0002903
13,67 ||| Statistical Analysis ||| 2.18 ||| This randomized trial was carried out and reported in accordance to the CONSORT statement 10 and the CONSORT explanation and elaboration document.,I,randomized trial carried reported consort statement 10 consort explanation elaboration document,C0034656|C0008976|C0206243|C0684224|G0000000|C1710187|C0450371|G0000000|C0681841|G0000000|C1301746
14,"95 ||| DISCUSSION ||| 3.19 ||| By investigating the selection of the venous cannulation at the forearm, it was expected that a difference in the withdrawal movement according to the selection of veins would be detected, but without significance.",O,investigating selection venous cannulation forearm expected difference withdrawal movement selection veins detected significance,C1292732|C0036576|C0042449|C0917707|C0016536|C1517001|C1705241|C2349954|C0026649|C0036576|C0042449|C0442726|C0237881
15,"103 ||| DISCUSSION ||| 3.27 ||| Third, the start of sevoflurane after rocuronium injection is not congruent with common clinical practice.",I,start sevoflurane rocuronium injection congruent common clinical practice,C0439659|C0074414|C0209337|C0021485|C0439853|C0205214|C0205210|C0237607
16,"63 ||| Statistical Analysis ||| 2.14 ||| Among the 194 patients, 3 patients in the fentanyl group and 1 patient in the saline group did not complete the study because they met exclusion criteria during the study process.",P,194 patients 3 patients fentanyl 1 patient saline complete study met exclusion criteria study process,C1442061|C0030705|G0000000|C0030705|C0015846|G0000000|C0030705|C0036082|C0205197|C0557651|C0268621|C0680251|C0243161|C0557651|C1184743
17,86 ||| DISCUSSION ||| 3.10 ||| Additional application of venous tourniquets in future studies could be performed to verify the peripheral analgesic effects of hydromorphone.,O,additional application venous tourniquets future studies performed verify peripheral analgesic effects hydromorphone,C1524062|C0185125|C0042449|C0040519|C0016884|C0947630|C0884358|C1711411|C0205100|C0002771|C1280500|C0012306
18,"98 ||| DISCUSSION ||| 3.22 ||| Therefore, equianalgesic doses of hydromorphone 0.03 mg/kg to fentanyl 2 ␮g/kg were used.",I,equianalgesic doses hydromorphone 0 03 mg/kg fentanyl 2 g/kg,G0000000|C0178602|C0012306|G0000000|C0450371|C0439272|C0015846|G0000000|C1300563
19,20 ||| PATIENTS AND METHODS ||| 1.4 ||| Patients aged 20 to 70 years who had an American Society of Anesthesiologists physical status I or II and were undergoing general anesthesia for elective gastric or colorectal surgery from August 2008 to January 2009 were enrolled consecutively in this study.,P,patients aged 20 70 american society anesthesiologists physical status ii undergoing anesthesia elective gastric colorectal surgery august 2008 january 2009 enrolled consecutively study,C0030705|C0001779|C0450371|C0450371|C0596070|C0037455|C0334910|C0031809|C0449438|G0000000|G0000000|C0002903|C0206058|C0038351|C0555952|C0038894|C3831448|G0000000|C3829466|G0000000|G0000000|G0000000|C0557651
20,"37 ||| PATIENTS AND METHODS ||| 1.21 ||| Then, 2.5% thiopental sodium 5 mg/kg was injected over 5 seconds.",I,2 5% thiopental sodium 5 mg/kg injected 5,G0000000|G0000000|C0039925|C0037473|G0000000|C0439272|C1720154|G0000000
21,90 ||| DISCUSSION ||| 3.14 ||| The status of vocal cord relaxation and the incidence of patient movement during tracheal intubation showed no statistical difference among the 3 groups.,N,status vocal cord relaxation incidence patient movement tracheal intubation statistical difference 3,C0449438|C0205382|C1550235|C0035028|C0021149|C0030705|C0026649|C0040578|C0021925|C0038215|C1705241|G0000000
22,21 ||| PATIENTS AND METHODS ||| 1.5 ||| Enrollment of patients was evaluated through preanesthetic rounds and determined by 2 anesthesiologists (E.Y.J.,N,enrollment patients evaluated preanesthetic rounds determined 2 anesthesiologists,C1516879|C0030705|C0220825|G0000000|C0332490|G0000000|G0000000|C0334910
23,"55 ||| Statistical Analysis ||| 2.6 ||| The hemodynamic parameters among groups, including MAP and HR differences before and after intubation, were compared using Kruskal-Wallis test with post hoc analysis by Tukey test using ranking.",O,hemodynamic parameters including map hr differences intubation compared kruskal-wallis test post hoc analysis tukey test ranking,C0019010|C0449381|C0332257|C0024779|G0000000|C1705241|C0021925|C1707455|G0000000|C0022885|C0687676|G0000000|C0002778|G0000000|C0022885|C0699794
24,"15 |||  ||| 0.15 ||| The peripherally mediated immediate analgesic property of hydromorphone may work to reduce intravenous rocuronium injection pain by inhibiting the activation of the peripheral nociceptors, 4,5 and, with its centrally mediated analgesic effect, may also produce earlier systemic effect than expected.",O,peripherally mediated analgesic property hydromorphone reduce intravenous rocuronium injection pain inhibiting activation peripheral nociceptors 4 5 centrally mediated analgesic produce earlier systemic expected,G0000000|C0086597|C0002771|C0871161|C0012306|G0000000|C0348016|C0209337|C0021485|C0030193|C3463820|C1879547|C0205100|C0028246|G0000000|G0000000|G0000000|C0086597|C0002771|G0000000|C1279919|C0205373|C1517001
25,"124 ||| ACKNOWLEDGMENTS ||| 5.12 ||| Incidence of patient movements, status of vocal cord relaxation during tracheal intubation, and intubation time.ϭ 1.0 *Intubation time was defined as the time from mouth opening to obtaining an appropriate capnographic trace.† P values for intubation time compared with the saline group.‡ P values compared with the fentanyl group.",O,incidence patient movements status vocal cord relaxation tracheal intubation intubation time 1 0 *intubation time defined time mouth obtaining capnographic trace values intubation time compared saline values compared fentanyl,C0021149|C0030705|C0026649|C0449438|C0205382|C1550235|C0035028|C0040578|C0021925|C0021925|C0040223|G0000000|G0000000|C0021925|C0040223|C1704788|C0040223|C0226896|C1301820|C0376529|C0442822|C0042295|C0021925|C0040223|C1707455|C0036082|C0042295|C1707455|C0015846
26,"57 ||| Statistical Analysis ||| 2.8 ||| The incidence of patient movements and the status of vocal cord relaxation during tracheal intubation were analyzed using ␹ 2 test and Fisher exact test, respectively.",N,incidence patient movements status vocal cord relaxation tracheal intubation analyzed 2 test fisher exact test,C0021149|C0030705|C0026649|C0449438|C0205382|C1550235|C0035028|C0040578|C0021925|C0936012|G0000000|C0022885|C0325045|C2828393|C0022885
27,29 ||| PATIENTS AND METHODS ||| 1.13 ||| The patient and 2 anesthesiologists carrying out the induction and recording the outcomes were all blinded to treatment group.,N,patient 2 anesthesiologists carrying induction recording outcomes blinded treatment,C0030705|G0000000|C0334910|C0206243|C0205263|G0000000|C1274040|C0150108|C0039798
28,"112 ||| CONCLUSIONS ||| 4.4 ||| Because using hydromorphone as an adjuvant agent during induction and the intraoperative period is relatively novel, additional studies on the optimal use and doses of hydromorphone during the induction of anesthesia and intraoperative periods are needed.",I,hydromorphone adjuvant agent induction intraoperative period additional studies optimal doses hydromorphone induction anesthesia intraoperative periods,C0012306|C0001551|C0450442|C0205263|C0456904|C0439531|C1524062|C0947630|C2698651|C0178602|C0012306|C0205263|C0002903|C0456904|C0439531
29,"114 ||| ACKNOWLEDGMENTS ||| 5.2 ||| This manuscript was presented, in part, for poster presentation at the Canadian Anesthesiologists' Society 2010 Annual Meeting, Montreal, Quebec, Canada, June 2010.",N,manuscript poster presentation canadian anesthesiologists society 2010 annual meeting montreal quebec canada june 2010,C0600659|C0376675|C0449450|C0238884|C0334910|C0037455|G0000000|C0332181|C0556656|G0000000|C0034390|C0006823|C3829443|G0000000
30,"78 ||| DISCUSSION ||| 3.2 ||| Hydromorphone has 5 to 7 times more potent analgesic efficacy than morphine, with a similar or lower incidence of adverse effects.",N,hydromorphone 5 7 times potent analgesic efficacy morphine lower incidence adverse effects,C0012306|G0000000|G0000000|C0040223|C3245505|C0002771|C1280519|C0026549|C0441994|C0021149|G0000000|C1280500
31,76 ||| Statistical Analysis ||| 2.27 ||| No significant between-group differences were found in the incidence of movements during intubation (12 patients [18.5%] in the hydromorphone group; 12 [17.9%] in the fentanyl group; and 20,O,between-group differences incidence movements intubation 12 patients 18 5% hydromorphone 12 17 9% fentanyl 20,C0441833|C1705241|C0021149|C0026649|C0021925|C0450371|C0030705|C0450371|G0000000|C0012306|C0450371|C0450371|G0000000|C0015846|C0450371
32,33 ||| PATIENTS AND METHODS ||| 1.17 ||| Patients with intravenous cannulation located elsewhere than at the veins of the forearm were excluded from the study.,N,patients intravenous cannulation located veins forearm excluded study,C0030705|C0348016|C0917707|G0000000|C0042449|C0016536|C1554077|C0557651
33,"49 ||| PATIENTS AND METHODS ||| 1.33 ||| If there was an increase in HR (Ͼ40% in baseline) and/or increased blood pressure with ST change in electrocardiography after intubation, IV esmolol (0.3 mg/kg) was available for administration.",I,increase hr 40% baseline and/or increased blood pressure st change electrocardiography intubation iv esmolol 0 3 mg/kg administration,C0442805|G0000000|C0450371|C0168634|G0000000|C0205217|C0005767|C0033095|C0036056|C0392747|C0013798|C0021925|C0022326|C0116569|G0000000|G0000000|C0439272|C0001554
34,75 ||| Statistical Analysis ||| 2.26 ||| No patients required administration of IV esmolol after intubation.,I,patients required administration iv esmolol intubation,C0030705|C1514873|C0001554|C0022326|C0116569|C0021925
35,42 ||| PATIENTS AND METHODS ||| 1.26 ||| Sevoflurane was started after the rocuronium injection and was adjusted to maintain an end-tidal concentration of 2.5 to 3.0 vol% in 100% oxygen.,I,sevoflurane started rocuronium injection adjusted maintain end-tidal concentration 2 5 3 0 vol% 100% oxygen,C0074414|C1272689|C0209337|C0021485|C0456081|C0024501|C0444930|C0004268|G0000000|G0000000|G0000000|G0000000|C0449468|C1442061|C0030054
36,28 ||| PATIENTS AND METHODS ||| 1.12 ||| The anesthesiologists (S.Y.L.,N,anesthesiologists,C0334910
37,"88 ||| DISCUSSION ||| 3.12 ||| However, opioid pretreatments are used not only for reducing the withdrawal movement but also to attenuate hemodynamic changes due to tracheal intubation.",O,opioid pretreatments reducing withdrawal movement attenuate hemodynamic tracheal intubation,C0242402|C1550147|C0392756|C2349954|C0026649|C0599946|C0019010|C0040578|C0021925
38,"108 ||| DISCUSSION ||| 3.32 ||| In such respects, the benefits of using an opioid as a pretreatment or adjuvant agent may be questionable; however, clinical implication lies more in its use to debilitated patients in whom sympathetic stimulation might cause detrimental clinical consequences, such as myocardial ischemia or hypertensive events.",O,respects benefits opioid pretreatment adjuvant agent questionable clinical implication lies debilitated patients sympathetic stimulation detrimental clinical consequences myocardial ischemia hypertensive events,C0679133|C0814225|C0242402|C1550147|C0001551|C0450442|C0332241|C0205210|G0000000|G0000000|G0000000|C0030705|G0000000|C1292856|G0000000|C0205210|C0686907|C0027061|C0022116|C0857121|C0441471
39,"81 ||| DISCUSSION ||| 3.5 ||| In terms of onset of action, hydromorphone may not be appropriate for procedures that require a rapid onset time.",N,terms onset action hydromorphone procedures require rapid onset time,C0233324|C0206132|C0441472|C0012306|C0025664|G0000000|C0456962|C0206132|C0040223
40,"17 ||| PATIENTS AND METHODS ||| 1.1 ||| This double-blind, randomized, controlled study was conducted at the Samsung Seoul Hospital, Samsung Medical Center in Seoul, Korea.",I,double-blind randomized controlled study conducted samsung seoul hospital samsung medical center seoul korea,C0013072|C0034656|C2587213|C0557651|C0004927|G0000000|C3850150|C0019994|G0000000|C0199168|C0205099|C3850150|C0022771
41,"43 ||| PATIENTS AND METHODS ||| 1.27 ||| Two minutes after the rocuronium injection, the anesthesiologist, who had more than 4 years of experience in anesthetic practice, performed tracheal intubation and applied controlled ventilation to maintain normocarbia without ballooning the cuff for 1 minute to avoid stimulation.",I,minutes rocuronium injection anesthesiologist 4 experience anesthetic practice performed tracheal intubation applied controlled ventilation maintain normocarbia ballooning cuff 1 minute avoid stimulation,C0439232|C0209337|C0021485|C0334910|G0000000|C0237607|C0002932|C0237607|C0884358|C0040578|C0021925|C4048755|C2587213|C0035203|C0024501|G0000000|C0004704|C0441107|G0000000|C0439232|G0000000|C1292856
42,45 ||| PATIENTS AND METHODS ||| 1.29 ||| Anesthesia was maintained with sevoflurane (end-tidal concentration of 2 to 3 vol%).,I,anesthesia maintained sevoflurane end-tidal concentration 2 3 vol%,C0002903|C1314677|C0074414|C0444930|C0004268|G0000000|G0000000|C0449468
43,"70 ||| Statistical Analysis ||| 2.21 ||| The number of patients with intravenous cannulation at the cephalic vein were 45, 42, and 46 in the hydromorphone, fentanyl, and saline groups, respectively.",I,patients intravenous cannulation cephalic vein 45 42 46 hydromorphone fentanyl saline,C0030705|C0348016|C0917707|C0205096|C0042449|C0450371|C0450371|C0450371|C0012306|C0015846|C0036082
44,54 ||| Statistical Analysis ||| 2.5 ||| The changes in MAP and HR within each group from the baseline to before and after tracheal intubation were analyzed by repeatedmeasures ANOVA with Bonferroni adjustment.,I,map hr baseline tracheal intubation analyzed repeatedmeasures anova bonferroni adjustment,C0024779|G0000000|C0168634|C0040578|C0021925|C0936012|G0000000|G0000000|G0000000|C0376209
45,"6 |||  ||| 0.6 ||| Methods: In this double-blind, randomized, controlled study, consecutive adult patients aged 20 to 70 years who were scheduled to undergo general anesthesia for elective gastric or colorectal surgery at the Samsung Seoul Hospital (Seoul, Republic of Korea) were randomly assigned to receive 5 mL hydromorphone 0.03 mg/kg or fentanyl 2 ␮g/kg or normal saline.",P,methods double-blind randomized controlled study consecutive adult patients aged 20 70 scheduled undergo anesthesia elective gastric colorectal surgery samsung seoul hospital seoul republic korea randomly assigned receive 5 hydromorphone 0 03 mg/kg fentanyl 2 g/kg normal saline,C0025663|C0013072|C0034656|C2587213|C0557651|C1707491|C0001675|C0030705|C0001779|C0450371|C0450371|C0086960|G0000000|C0002903|C0206058|C0038351|C0555952|C0038894|G0000000|C3850150|C0019994|C3850150|G0000000|C0022771|G0000000|C1516050|C1514756|G0000000|C0012306|G0000000|C0450371|C0439272|C0015846|G0000000|C1300563|C0205307|C0036082
46,96 ||| DISCUSSION ||| 3.20 ||| This study had several limitations.,N,study limitations,C0557651|C0449295
47,68 ||| Statistical Analysis ||| 2.19 ||| The intravenous cannulation sites at the forearm were similar in all 3 groups.,N,intravenous cannulation sites forearm 3,C0348016|C0917707|C0205145|C0016536|G0000000
48,72 ||| Statistical Analysis ||| 2.23 ||| An 18-gauge intravenous cannula was used for all patients except 1 patient in the saline group who had a 20-gauge intravenous line.,I,18-gauge intravenous cannula patients 1 patient saline 20-gauge intravenous,C0450371|C0348016|C0520453|C0030705|G0000000|C0030705|C0036082|C0450371|C0348016
49,"7 |||  ||| 0.7 ||| Thirty seconds after administering the study drug, anesthesia was induced with 2.5% thiopental sodium 5 mg/kg.",I,thirty administering study drug anesthesia induced 2 5% thiopental sodium 5 mg/kg,C3816446|C1533734|C0557651|C0013227|C0002903|C0205263|G0000000|G0000000|C0039925|C0037473|G0000000|C0439272
50,30 ||| PATIENTS AND METHODS ||| 1.14 ||| The syringes were stored at room temperature.,N,syringes stored temperature,C0039142|C1698986|C0005903
51,"59 ||| Statistical Analysis ||| 2.10 ||| The number of patients in the study was determined based on a pilot study, with an estimated incidence of 45% and 15% withdrawal movement in the saline and hydromorphone groups, respectively.",I,patients study determined based pilot study estimated incidence 45% 15% withdrawal movement saline hydromorphone,C0030705|C0557651|G0000000|C1527178|C0473169|C0557651|C0750572|C0021149|C0450371|C0450371|C2349954|C0026649|C0036082|C0012306
52,"89 ||| DISCUSSION ||| 3.13 ||| Taking this into account, we used hydromorphone as the study agent to affect rocuronium withdrawal movement and hemodynamic profile.",O,account hydromorphone study agent affect rocuronium withdrawal movement hemodynamic profile,C2741673|C0012306|C0557651|C0450442|C0001721|C0209337|C2349954|C0026649|C0019010|C1979963
53,"64 ||| Statistical Analysis ||| 2.15 ||| Exclusion criteria were patients with laryngeal view grade 3 or 4 with no visualization of the vocal cords during tracheal intubation, 9 or any other conditions that would affect vocal cord assessment such as vocal cord spasm, and patients with an intravenous route other than the forearm.",P,exclusion criteria patients laryngeal view grade 3 4 visualization vocal cords tracheal intubation 9 conditions affect vocal cord assessment vocal cord spasm patients intravenous route forearm,C0680251|C0243161|C0030705|C0023078|C0449911|C0441800|G0000000|G0000000|C0175631|C0205382|C1550235|C0040578|C0021925|G0000000|C0012634|C0001721|C0205382|C1550235|C1261322|C0205382|C1550235|C0026821|C0030705|C0348016|C0013153|C0016536
54,69 ||| Statistical Analysis ||| 2.20 ||| The most common intravenous cannulation site was the cephalic vein.,I,common intravenous cannulation site cephalic vein,C0205214|C0348016|C0917707|C0205145|C0205096|C0042449
55,122 ||| ACKNOWLEDGMENTS ||| 5.10 ||| Patients' characteristics (N ‫؍‬ 194).,N,patients characteristics 194,C0030705|C1521970|C1442061
56,"23 ||| PATIENTS AND METHODS ||| 1.7 ||| The exclusion criteria were as follows: known allergy and contraindication to opioids; history of diabetes mellitus, asthma, or neurological deficit; pregnancy; or use of analgesics or sedatives within the 24 hours before surgery.",P,exclusion criteria allergy contraindication opioids history diabetes mellitus asthma neurological deficit pregnancy analgesics sedatives 24 hours surgery,C0680251|C0243161|C0002111|C0522473|C0242402|C0019664|C0011847|G0000000|C0004096|C0205494|C0162429|C0032961|C0002771|C0036557|C0450371|C0439227|C0038894
57,"87 ||| DISCUSSION ||| 3.11 ||| Therefore, if opioids with delayed onset displayed prompt analgesic effect on injection followed by immediate rocuronium administration, peripheral analgesia of opioid may be suspected more prominently.",I,opioids delayed onset displayed prompt analgesic injection rocuronium administration peripheral analgesia opioid suspected prominently,C0242402|C0205421|C0206132|C0870432|C0871157|C0002771|C0021485|C0209337|C0001554|C0205100|C0002766|C0242402|C0332147|G0000000
58,5 |||  ||| 0.5 ||| Objective: The aim of this study was to compare the effects of pretreatment with hydromorphone in reducing rocuronium-induced withdrawal movements and hemodynamic changes during tracheal intubation with the effects of fentanyl and normal saline.,P,objective aim study compare effects pretreatment hydromorphone reducing rocuronium-induced withdrawal movements hemodynamic tracheal intubation effects fentanyl normal saline,C0018017|C1947946|C0557651|C1707455|C1280500|C1550147|C0012306|C0392756|C0209337|C2349954|C0026649|C0019010|C0040578|C0021925|C1280500|C0015846|C0205307|C0036082
59,56 ||| Statistical Analysis ||| 2.7 ||| P value was corrected by Bonferroni adjustment because of multiple testing.,N,corrected bonferroni adjustment multiple testing,C0205202|G0000000|C0376209|C0439064|C0039593
60,"119 ||| ACKNOWLEDGMENTS ||| 5.7 ||| Suk Young Lee designed, performed the study, data analysis, revising and final approval of the article.",N,suk lee designed performed study data analysis revising final approval article,C1556071|G0000000|C1707689|C0884358|C0557651|C1511726|C0002778|C1527075|C0205088|C0205540|C1706852
61,"24 ||| PATIENTS AND METHODS ||| 1.8 ||| Random allocation of patients into 1 of 3 groups to receive 5 mL of either IV hydromorphone hydrochloride* 0.03 mg/kg (n ϭ 65) or IV fentanyl citrate 2 ␮g/kg (n ϭ 67; Gu Ju Pharm, Seoul, Korea) or IV saline (n ϭ 62; sodium chloride, Joong Wae Pharm, Seoul, Korea) was facilitated by using a computer-generated random number concealed in an envelope.",I,random allocation patients 1 3 receive 5 iv hydromorphone hydrochloride* 0 03 mg/kg 65 iv fentanyl citrate 2 g/kg 67 gu ju pharm seoul korea iv saline 62 sodium chloride joong wae pharm seoul korea facilitated computer-generated random concealed envelope,C0034656|C1706778|C0030705|G0000000|G0000000|C1514756|G0000000|C0022326|C0012306|C1512523|G0000000|C0450371|C0439272|C0450371|C0022326|C0015846|C0008857|G0000000|C1300563|C0450371|C3887515|G0000000|G0000000|C3850150|C0022771|C0022326|C0036082|C0450371|C0037473|C0008203|G0000000|G0000000|G0000000|C3850150|C0022771|G0000000|C0009622|C0034656|C0443189|C1622204
62,"51 ||| Statistical Analysis ||| 2.2 ||| The data are reported as mean (SD), median (interquartile range), or number (proportion) of patients.",O,data reported sd median interquartile range proportion patients,C1511726|C0684224|C2699239|C0549183|G0000000|C1514721|C1709707|C0030705
63,111 ||| CONCLUSIONS ||| 4.3 ||| These may be attributed both to central and peripheral antinociceptive effects of opioids.,N,attributed central peripheral antinociceptive effects opioids,C0449234|C0205099|C0205100|G0000000|C1280500|C0242402
64,"123 ||| ACKNOWLEDGMENTS ||| 5.11 ||| Incidence of patient movements, status of vocal cord relaxation during tracheal intubation, and intubation time.ϭ 1.0 *Intubation time was defined as the time from mouth opening to obtaining an appropriate capnographic trace.",O,incidence patient movements status vocal cord relaxation tracheal intubation intubation time 1 0 *intubation time defined time mouth obtaining capnographic trace,C0021149|C0030705|C0026649|C0449438|C0205382|C1550235|C0035028|C0040578|C0021925|C0021925|C0040223|G0000000|G0000000|C0021925|C0040223|C1704788|C0040223|C0226896|C1301820|C0376529|C0442822
65,"91 ||| DISCUSSION ||| 3.15 ||| However, patients in the saline group presented more movements during intubation than those in the hydromorphone and fentanyl groups.",I,patients saline movements intubation hydromorphone fentanyl,C0030705|C0036082|C0026649|C0021925|C0012306|C0015846
66,"41 ||| PATIENTS AND METHODS ||| 1.25 ||| The 2 investigators were educated beforehand to grade patients' responses according to the scale proposed by Shevchenko and colleagues 8  2 ϭ movement at the wrist only; 3 ϭ movement/withdrawal involving the arm only (elbow/shoulder); 4 ϭ generalized response, withdrawal or movement in more than 1 extremity.",O,2 investigators educated grade patients responses scale proposed shevchenko colleagues 8 2 movement wrist 3 movement/withdrawal involving arm elbow/shoulder 4 generalized response withdrawal movement 1 extremity,G0000000|C0035173|C0039401|C0441800|C0030705|C0871261|C0175659|C1553874|G0000000|G0000000|G0000000|G0000000|C0026649|C0043262|G0000000|C0026649|C1314939|C0446516|C0013769|G0000000|C0205246|C0871261|C2349954|C0026649|G0000000|C0015385
67,"109 ||| CONCLUSIONS ||| 4.1 ||| Compared with saline, hydromorphone produced immediate analgesia to rocuronium painϪinduced withdrawal movement and reduced hemodynamic responses to tracheal intubation.",O,compared saline hydromorphone produced analgesia rocuronium paininduced withdrawal movement reduced hemodynamic responses tracheal intubation,C1707455|C0036082|C0012306|G0000000|C0002766|C0209337|G0000000|C2349954|C0026649|C0392756|C0019010|C0871261|C0040578|C0021925
68,"60 ||| Statistical Analysis ||| 2.11 ||| At least 53 patients were required for each group to achieve a 30% reduction in the withdrawal movement at the significance level of 5% and power of 90%, and considering the possibility of unanticipated exclusions (10%).",N,53 patients required achieve 30% reduction withdrawal movement significance level 5% power 90% possibility unanticipated exclusions 10%,C0450371|C0030705|C1514873|G0000000|C0450371|C0301630|C2349954|C0026649|C0237881|C0441889|G0000000|C0032863|C0450371|C0332149|G0000000|C0680251|C0450371
69,61 ||| Statistical Analysis ||| 2.12 ||| P Ͻ 0.05 was considered significant.,N,0 05 considered,G0000000|C0450371|C0750591
70,77 ||| DISCUSSION ||| 3.1 ||| This study suggests that hydromorphone may be as effective as fentanyl as a pretreatment drug in reducing withdrawal movements due to rocuronium injection pain and inducing general anesthesia without delay.,O,study suggests hydromorphone effective fentanyl pretreatment drug reducing withdrawal movements rocuronium injection pain inducing anesthesia delay,C0557651|C1705535|C0012306|C1280519|C0015846|C1550147|C0013227|C0392756|C2349954|C0026649|C0209337|C0021485|C0030193|C0205263|C0002903|C0205421
71,3 |||  ||| 0.3 ||| The opioid receptors are known to be present in peripheral sensory nerve terminals as well as in the dorsal root ganglion and the central terminal of primary afferent nerves.,N,opioid receptors peripheral sensory nerve terminals dorsal root ganglion central terminal primary afferent nerves,C0242402|C0597357|C0205100|C0445254|C0027740|C0205088|C0205095|C0040452|C0017067|C0205099|C0205088|C0205225|C0205115|C0027740
72,"117 ||| ACKNOWLEDGMENTS ||| 5.5 ||| Tae Hyeong Kim was responsible for the conception, data collection, revising and final approval of the article.",N,tae hyeong kim responsible conception data collection revising final approval article,C3163695|G0000000|G0000000|C1273518|C0009637|C1511726|C1516698|C1527075|C0205088|C0205540|C1706852
73,110 ||| CONCLUSIONS ||| 4.2 ||| These findings were comparable with pretreatment with fentanyl.,O,findings comparable pretreatment fentanyl,C2607943|G0000000|C1550147|C0015846
74,"40 ||| PATIENTS AND METHODS ||| 1.24 ||| Two anesthesiologists, the one who administered the study drug and another to conduct anesthetic induction, assessed the patient response during and immediately after rocuronium injection.",I,anesthesiologists administered study drug conduct anesthetic induction assessed patient response rocuronium injection,C0334910|C1521801|C0557651|C0013227|C0004927|C0002932|C0205263|C1516048|C0030705|C0871261|C0209337|C0021485
75,25 ||| PATIENTS AND METHODS ||| 1.9 ||| One of 2 anesthesiologists (S.Y.L.,N,2 anesthesiologists,G0000000|C0334910
76,"34 ||| PATIENTS AND METHODS ||| 1.18 ||| All patients received continuous electrocardiography, noninvasive arterial pressure, capnography, and end-tidal sevoflurane monitoring.",I,patients received continuous electrocardiography noninvasive arterial pressure capnography end-tidal sevoflurane monitoring,C0030705|C1514756|C0549178|C0013798|C0205303|C0003842|C0033095|C0376529|C0444930|C0074414|C0150369
77,85 ||| DISCUSSION ||| 3.9 ||| Opioid analgesia is obtained via the central and peripheral opioid receptors.,N,opioid analgesia central peripheral opioid receptors,C0242402|C0002766|C0205099|C0205100|C0242402|C0597357
78,"84 ||| DISCUSSION ||| 3.8 ||| This observation of instantaneous onset of pain subsidence to rocuronium injection may require explanations other than its centrally mediated analgesia, which take at least 5 minutes to be effective.",O,observation instantaneous onset pain subsidence rocuronium injection require explanations centrally mediated analgesia 5 minutes effective,C0302523|G0000000|C0206132|C0030193|G0000000|C0209337|C0021485|G0000000|C0681841|G0000000|C0086597|C0002766|G0000000|C0439232|C1280519
79,"118 ||| ACKNOWLEDGMENTS ||| 5.6 ||| Byung Seop Shin performed the study, analysis and interpretation of data, revising and final approval of the article.",N,byung seop shin performed study analysis interpretation data revising final approval article,G0000000|G0000000|C0230444|C0884358|C0557651|C0002778|C0459471|C1511726|C1527075|C0205088|C0205540|C1706852
80,"74 ||| Statistical Analysis ||| 2.25 ||| The incidence of wrist, arm, and generalized movements was higher in the fentanyl group (1.5%, 3.0%, and 3.0%, respectively) than in the hydromorphone group (1.5%, 0%, and 1.5%, respectively), but without statistical significance.",I,incidence wrist arm generalized movements fentanyl 1 5% 3 0% 3 0% hydromorphone 1 5% 0% 1 5% statistical significance,C0021149|C0043262|C0446516|C0205246|C0026649|C0015846|G0000000|G0000000|G0000000|G0000000|G0000000|G0000000|C0012306|G0000000|G0000000|G0000000|G0000000|G0000000|C0038215|C0237881
81,"105 ||| DISCUSSION ||| 3.29 ||| Fourth, hydromorphone is less emetogenic than the fentanyl derivatives 12,21,22 ; however, we did not observe the incidence or severity of postoperative nausea and vomiting in this study.",O,fourth hydromorphone emetogenic fentanyl derivatives 12 21 22 observe incidence severity postoperative nausea vomiting study,C0205438|C0012306|C0013973|C0015846|C0243072|C0450371|C0450371|C0450371|C1441672|C0021149|C0439793|C0032790|C0027497|C0042963|C0557651
82,"92 ||| DISCUSSION ||| 3.16 ||| This finding may suggest that despite the reportedly adequate muscle relaxation with rocuronium 0.6 mg/kg, adjuvant drugs, such as hydromorphone and fentanyl, are required to deepen the level of anesthesia and suppress movement during the strong stimulus of tracheal intubation.",O,finding reportedly adequate muscle relaxation rocuronium 0 6 mg/kg adjuvant drugs hydromorphone fentanyl required deepen level anesthesia suppress movement strong stimulus tracheal intubation,C0037088|G0000000|C0205410|C0026845|C0035028|C0209337|G0000000|G0000000|C0439272|C0001551|C0013227|C0012306|C0015846|C1514873|G0000000|C0441889|C0002903|C1260953|C0026649|C0442821|C0234402|C0040578|C0021925
83,"97 ||| DISCUSSION ||| 3.21 ||| First, there are no established recommended doses of hydromorphone for the induction of anesthesia.",I,established recommended doses hydromorphone induction anesthesia,C0443211|C0034866|C0178602|C0012306|C0205263|C0002903
84,"102 ||| DISCUSSION ||| 3.26 ||| The maximum onset of action for hydromorphone is 10 to 20 minutes 17 ; therefore, a longer period of observation would have been appreciated.",N,maximum onset action hydromorphone 10 20 minutes 17 period observation appreciated,C0806909|C0206132|C0441472|C0012306|C0450371|C0450371|C0439232|C0450371|C0439531|C0302523|G0000000
85,"11 |||  ||| 0.11 ||| The overall incidence of withdrawal movements was significantly lower in the hydromorphone group (2 patients; 3.1%) and the fentanyl group (5 patients; 7.5%) (both, P Ͻ 0.001) than in the saline group (36 patients; 58.1%).",I,incidence withdrawal movements lower hydromorphone 2 patients 3 1% fentanyl 5 patients 7 5% 0 001 saline 36 patients 58 1%,C0021149|C2349954|C0026649|C0441994|C0012306|G0000000|C0030705|G0000000|G0000000|C0015846|G0000000|C0030705|G0000000|G0000000|G0000000|C1442061|C0036082|C0450371|C0030705|C0450371|G0000000
86,13 |||  ||| 0.13 ||| Conclusions: Pretreatment with hydromorphone and fentanyl may have similar effectiveness in reducing withdrawal movements in response to rocuronium injection pain and inducing immediate general anesthesia.,O,conclusions pretreatment hydromorphone fentanyl effectiveness reducing withdrawal movements response rocuronium injection pain inducing anesthesia,C1707478|C1550147|C0012306|C0015846|C1280519|C0392756|C2349954|C0026649|C0871261|C0209337|C0021485|C0030193|C0205263|C0002903
87,"62 ||| Statistical Analysis ||| 2.13 ||| A total of 194 patients (hydromorphone group, n ϭ 65; fentanyl group, n ϭ 67; and saline group, n ϭ 62) were enrolled consecutively between August 2008 and January 2009.",P,total 194 patients hydromorphone 65 fentanyl 67 saline 62 enrolled consecutively august 2008 january 2009,C0439175|C1442061|C0030705|C0012306|C0450371|C0015846|C0450371|C0036082|C0450371|G0000000|G0000000|C3831448|G0000000|C3829466|G0000000
88,100 ||| DISCUSSION ||| 3.24 ||| It is possible that hydromorphone 0.03 mg/kg might have a lower or higher analgesic effect than fentanyl 2 ␮g/kg.,I,hydromorphone 0 03 mg/kg lower analgesic fentanyl 2 g/kg,C0012306|G0000000|C0450371|C0439272|C0441994|C0002771|C0015846|G0000000|C1300563
89,58 ||| Statistical Analysis ||| 2.9 ||| The intubation time was compared using KruskalWallis test with post hoc analysis by Tukey test using ranking.,O,intubation time compared kruskalwallis test post hoc analysis tukey test ranking,C0021925|C0040223|C1707455|G0000000|C0022885|C0687676|G0000000|C0002778|G0000000|C0022885|C0699794
90,"4 |||  ||| 0.4 ||| Therefore, we hypothesized that hydromorphone may be considered a potent pretreatment or adjuvant drug during the induction of anesthesia with its peripherally and centrally mediated analgesia.",P,hypothesized hydromorphone considered potent pretreatment adjuvant drug induction anesthesia peripherally centrally mediated analgesia,G0000000|C0012306|C0750591|C3245505|C1550147|C0001551|C0013227|C0205263|C0002903|G0000000|G0000000|C0086597|C0002766
91,"48 ||| PATIENTS AND METHODS ||| 1.32 ||| The mean arterial pressure (MAP) and heart rate (HR) were measured on arrival at the operating room, 1 minute before intubation, and 1 minute after tracheal intubation.",I,arterial pressure map heart rate hr measured arrival operating 1 minute intubation 1 minute tracheal intubation,C0003842|C0033095|C0024779|C0018787|C0871208|G0000000|C0444706|C1555577|C3242339|G0000000|C0439232|C0021925|G0000000|C0439232|C0040578|C0021925
92,"50 ||| Statistical Analysis ||| 2.1 ||| Statistical analyses were carried out using SPSS 12.0 for Windows (SPSS Inc, Chicago, Illinois).",N,statistical analyses carried spss 12 0 windows spss chicago illinois,C0038215|C0002778|C0206243|C3813609|C0450371|G0000000|C0557702|C3813609|C0008044|C0020898
93,1 |||  ||| 0.1 ||| Background: Hydromorphone is a potent ␮-opioid selective agonist that has an onset time within 5 minutes and reaches peak effect between 10 and 20 minutes.,I,background hydromorphone potent -opioid selective agonist onset time 5 minutes reaches peak 10 20 minutes,C1706907|C0012306|C3245505|C0242402|C0036576|C2987634|C0206132|C0040223|G0000000|C0439232|C0596012|C0444505|C0450371|C0450371|C0439232
94,"115 ||| ACKNOWLEDGMENTS ||| 5.3 ||| Sang Hyun Lee was responsible for drafting and revising the article, conception, analysis of data, and final approval of the article.",N,sang hyun lee responsible drafting revising article conception analysis data final approval article,C1864650|G0000000|G0000000|C1273518|C1547277|C1527075|C1706852|C0009637|C0002778|C1511726|C0205088|C0205540|C1706852
95,"47 ||| PATIENTS AND METHODS ||| 1.31 ||| The intubation time, defined as the time from mouth opening to obtaining the appropriate capnographic trace, was measured in all patients.",N,intubation time defined time mouth obtaining capnographic trace measured patients,C0021925|C0040223|C1704788|C0040223|C0226896|C1301820|C0376529|C0442822|C0444706|C0030705
96,94 ||| DISCUSSION ||| 3.18 ||| The size and sites of the intravenous cannulas at 1 of the 6 superficial veins at the forearm were not different among groups.,I,size sites intravenous cannulas 1 6 superficial veins forearm,C0456389|C0205145|C0348016|C0520453|G0000000|G0000000|C0205124|C0042449|C0016536
97,"71 ||| Statistical Analysis ||| 2.22 ||| The next most common sites were accessory cephalic vein, basilic vein, and median antebrachial vein.",I,common sites accessory cephalic vein basilic vein median antebrachial vein,C0205214|C0205145|C2963249|C0205096|C0042449|G0000000|C0042449|C0549183|C0016536|C0042449
98,"32 ||| PATIENTS AND METHODS ||| 1.16 ||| On arrival at the operating room, the intravenous cannulation site and its patency were confirmed by the anesthesiologist.",O,arrival operating intravenous cannulation site patency confirmed anesthesiologist,C1555577|C3242339|C0348016|C0917707|C0205145|C0175566|C0521093|C0334910
99,"120 ||| ACKNOWLEDGMENTS ||| 5.8 ||| Eun Young Joo was responsible for the conception, interpretation of data, revising and final approval of the article.",N,eun joo responsible conception interpretation data revising final approval article,G0000000|G0000000|C1273518|C0009637|C0459471|C1511726|C1527075|C0205088|C0205540|C1706852
100,"93 ||| DISCUSSION ||| 3.17 ||| The time to facilitate intubation was different among the groups (P ϭ 0.032); however, their differences of approximately 2 seconds are not clinically significant.",O,time facilitate intubation 0 032 differences 2 clinically,C0040223|G0000000|C0021925|G0000000|C1442061|C1705241|G0000000|G0000000
101,"19 ||| PATIENTS AND METHODS ||| 1.3 ||| Written, informed consent was obtained from all subjects.",N,written informed consent subjects,C0043266|C1522154|C1511481|C0681850
102,"26 ||| PATIENTS AND METHODS ||| 1.10 ||| The syringes for both study drug and placebo were identical, labeled ""study drug"" to conceal treatment group allocation.",N,syringes study drug placebo identical labeled study drug conceal treatment allocation,C0039142|C0557651|C0013227|C0032042|C0205280|C1708632|C0557651|C0013227|C0443189|C0039798|C1706778
103,"73 ||| Statistical Analysis ||| 2.24 ||| The overall incidence of withdrawal movements was significantly lower in the hydromorphone group (2 patients; 3.1%) and the fentanyl group (5 patients; 7.5%) (both, P Ͻ 0.001) than in the saline group (36 patients; 58.1%).",I,incidence withdrawal movements lower hydromorphone 2 patients 3 1% fentanyl 5 patients 7 5% 0 001 saline 36 patients 58 1%,C0021149|C2349954|C0026649|C0441994|C0012306|G0000000|C0030705|G0000000|G0000000|C0015846|G0000000|C0030705|G0000000|G0000000|G0000000|C1442061|C0036082|C0450371|C0030705|C0450371|G0000000
104,"36 ||| PATIENTS AND METHODS ||| 1.20 ||| During preoxygenation with 100% oxygen, the study drug was injected over 30 seconds, and an investigator blinded to the study drug observed for signs of adverse events, such as apnea and coughing for 30 seconds, and questioned patients about adverse events just before injection of thiopental sodium.",I,preoxygenation 100% oxygen study drug injected 30 investigator blinded study drug observed signs adverse events apnea coughing 30 questioned patients adverse events injection thiopental sodium,C0412792|C1442061|C0030054|C0557651|C0013227|C1720154|C0450371|C0035173|C0150108|C0557651|C0013227|C1441672|C0220912|G0000000|C0441471|C0003578|C0010200|C0450371|C1522634|C0030705|G0000000|C0441471|C0021485|C0039925|C0037473
105,"83 ||| DISCUSSION ||| 3.7 ||| However, we found that patients in the hydromorphone group had effectively diminished rocuronium injection pain within 90 seconds after injection and blunt cardiovascular responses to tracheal intubation with the same efficacy as fentanyl.",O,patients hydromorphone effectively diminished rocuronium injection pain 90 injection blunt cardiovascular responses tracheal intubation efficacy fentanyl,C0030705|C0012306|G0000000|C0205216|C0209337|C0021485|C0030193|C0450371|C0021485|C1997138|C0007226|C0871261|C0040578|C0021925|C1280519|C0015846
106,35 ||| PATIENTS AND METHODS ||| 1.19 ||| All drugs were injected through the proximal rubber port connected to the intravenous cannula with a free flow of intravenous lactated Ringer solution.,I,drugs injected proximal rubber port connected intravenous cannula free flow intravenous lactated ringer solution,C0013227|C1720154|C0205107|C0035918|C0452253|C2986575|C0348016|C0520453|C0332296|C0806140|C0348016|C0022924|C1875730|C0037633
107,46 ||| PATIENTS AND METHODS ||| 1.30 ||| The time interval between the study drug injection and intubation was designed to be within 3 to 4 minutes in all patients.,N,time interval study drug injection intubation designed 3 4 minutes patients,C0040223|C1272706|C0557651|C0013227|C0021485|C0021925|C1707689|G0000000|G0000000|C0439232|C0030705
108,"12 |||  ||| 0.12 ||| The mean arterial pressure (MAP) and heart rate (HR) after intubation (median [interquartile range]) in the fentanyl group (101.5 [84Ϫ115] mm Hg; 93.5 [82Ϫ102 ] beats per minute [bpm]) and the hydromor-phone group (93.0 [83Ϫ106] mm Hg; 90.0 [86.3Ϫ93.6] bpm) were significantly lower than these measures in the saline group (111.5 [105Ϫ123] mm Hg; 103.5 [96Ϫ113] bpm) (fentanyl group MAP and HR, P Ͻ 0.001; hydromorphone group MAP and HR, P Ͻ 0.001).",I,arterial pressure map heart rate hr intubation median interquartile range fentanyl 101 5 84115 mm hg 93 5 82102 beats minute bpm hydromor-phone 93 0 83106 mm hg 90 0 86 393 6 bpm lower measures saline 111 5 105123 mm hg 103 5 96113 bpm fentanyl map hr 0 001 hydromorphone map hr 0 001,C0003842|C0033095|C0024779|C0018787|C0871208|G0000000|C0021925|C0549183|G0000000|C1514721|C0015846|C1442061|G0000000|G0000000|G0000000|C0025424|C0450371|G0000000|G0000000|G0000000|C0439232|G0000000|C1515258|C0450371|G0000000|G0000000|G0000000|C0025424|C0450371|G0000000|C0450371|C1442061|G0000000|G0000000|C0441994|C0079809|C0036082|C1442061|G0000000|G0000000|G0000000|C0025424|C1442061|G0000000|G0000000|G0000000|C0015846|C0024779|G0000000|G0000000|C1442061|C0012306|C0024779|G0000000|G0000000|C1442061
109,18 ||| PATIENTS AND METHODS ||| 1.2 ||| This study was approved by the Samsung Seoul Medical Center's institutional review board (No.,N,study approved samsung seoul medical centers institutional review board,C0557651|C0205540|G0000000|C3850150|C0199168|C0205099|C0018704|C0282443|C0972401
110,"38 ||| PATIENTS AND METHODS ||| 1.22 ||| After loss of consciousness and eyelash reflexes, when the appropriate end-tidal carbon dioxide curve appeared on capnography upon trial of mask ventilation with inspired oxygen fraction 1.0, rocuronium 0.6 mg/kg was injected over 5 seconds.",I,loss consciousness eyelash reflexes end-tidal carbon dioxide curve appeared capnography trial mask ventilation inspired oxygen fraction 1 0 rocuronium 0 6 mg/kg injected 5,C1517945|C0009791|C0015422|C0034929|C0444930|C0007009|C0678717|C0205134|C0700364|C0376529|C0008976|C0024861|C0035203|C0004048|C0030054|C1264633|G0000000|G0000000|C0209337|G0000000|G0000000|C0439272|C1720154|G0000000
111,82 ||| DISCUSSION ||| 3.6 ||| Hydromorphone has an onset time of 5 minutes and a peak effect time of 10 to 20 minutes.,I,hydromorphone onset time 5 minutes peak time 10 20 minutes,C0012306|C0206132|C0040223|G0000000|C0439232|C0444505|C0040223|C0450371|C0450371|C0439232
112,53 ||| Statistical Analysis ||| 2.4 ||| The incidence of withdrawal movements was analyzed using Fisher exact test.,N,incidence withdrawal movements analyzed fisher exact test,C0021149|C2349954|C0026649|C0936012|C0325045|C2828393|C0022885
113,"10 |||  ||| 0.10 ||| Results: A total of 194 patients were enrolled, with 65 in the hydromorphone group, 67 in the fentanyl group, and 62 in the saline group.",P,total 194 patients enrolled 65 hydromorphone 67 fentanyl 62 saline,C0439175|C1442061|C0030705|G0000000|C0450371|C0012306|C0450371|C0015846|C0450371|C0036082
114,"16 |||  ||| 0.16 ||| Therefore, we investigated the effectiveness of hydromorphone as a pretreatment drug to reduce the withdrawal movements in response to injection of rocuronium and to attenuate hemodynamic changes to tracheal intubation compared with that of fentanyl and saline.",O,investigated effectiveness hydromorphone pretreatment drug reduce withdrawal movements response injection rocuronium attenuate hemodynamic tracheal intubation compared fentanyl saline,C1292732|C1280519|C0012306|C1550147|C0013227|G0000000|C2349954|C0026649|C0871261|C0021485|C0209337|C0599946|C0019010|C0040578|C0021925|C1707455|C0015846|C0036082
115,39 ||| PATIENTS AND METHODS ||| 1.23 ||| The time interval between the study drug injection and rocuronium injection was set at Ͻ90 seconds in all patients.,I,time interval study drug injection rocuronium injection set 90 patients,C0040223|C1272706|C0557651|C0013227|C0021485|C0209337|C0021485|C0036849|C0450371|C0030705
116,"65 ||| Statistical Analysis ||| 2.16 ||| One patient (fentanyl group) had a percutaneously inserted central catheter instead of a peripheral intravenous line, another developed vocal cord spasm (saline group), and 2 patients (fentanyl group) did not show the vocal cords during intubation.",I,patient fentanyl percutaneously inserted central catheter peripheral intravenous developed vocal cord spasm saline 2 patients fentanyl vocal cords intubation,C0030705|C0015846|G0000000|C0441587|C0205099|C0085590|C0205100|C0348016|G0000000|C0205382|C1550235|C0026821|C0036082|G0000000|C0030705|C0015846|C0205382|C1550235|C0021925
117,113 ||| ACKNOWLEDGMENTS ||| 5.1 ||| The authors have indicated that they have no conflicts of interest regarding the content of this article.,N,authors conflicts content article,C3812881|C0009671|C0423896|C1706852
118,"79 ||| DISCUSSION ||| 3.3 ||| MEDLINE was searched (inception to 2010) using the following terms: hydromorphone, induction, anesthesia, preoperative, intraoperative, and analgesia.",O,medline searched inception 2010 terms hydromorphone induction anesthesia preoperative intraoperative analgesia,C0025141|C1706202|G0000000|G0000000|C0233324|C0012306|C0205263|C0002903|C0445204|C0456904|C0002766
119,44 ||| PATIENTS AND METHODS ||| 1.28 ||| Patient movement and status of vocal cord relaxation were observed during tracheal intubation.,N,patient movement status vocal cord relaxation observed tracheal intubation,C0030705|C0026649|C0449438|C0205382|C1550235|C0035028|C1441672|C0040578|C0021925
120,"66 ||| Statistical Analysis ||| 2.17 ||| Therefore, 190 patients (hydromorphone group, n ϭ 65; fentanyl group, n ϭ 64; and saline group, n ϭ 61) (mean [SD]  However, for an intent-to-treat analysis, the 194 initially enrolled patients were analyzed.",P,190 patients hydromorphone 65 fentanyl 64 saline 61 sd intent-to-treat analysis 194 initially enrolled patients analyzed,C1442061|C0030705|C0012306|C0450371|C0015846|C0450371|C0036082|C0450371|C2699239|C0162425|C0002778|C1442061|C0205265|G0000000|C0030705|C0936012
121,"9 |||  ||| 0.9 ||| Two minutes after rocuronium injection, tracheal intu-bation was performed and hemodynamic changes were observed.",O,minutes rocuronium injection tracheal intu-bation performed hemodynamic observed,C0439232|C0209337|C0021485|C0040578|C1825613|C0884358|C0019010|C1441672
122,"106 ||| DISCUSSION ||| 3.30 ||| Patients in the fentanyl and hydromorphone groups showed statistically significant hemodynamic stability compared with patients in the saline group; however, the patients in the latter group also did not show hemodynamic changes requiring esmolol administration.",O,patients fentanyl hydromorphone statistically hemodynamic stability compared patients saline patients hemodynamic requiring esmolol administration,C0030705|C0015846|C0012306|C0038215|C0019010|C0205360|C1707455|C0030705|C0036082|C0030705|C0019010|G0000000|C0116569|C0001554
123,"2 |||  ||| 0.2 ||| However, it may show immediate analgesic effect to rocuronium-induced pain because of its peripheral analgesic property and also may attenuate noxious stimuli from tracheal intubation during induction.",O,analgesic rocuronium-induced pain peripheral analgesic property attenuate noxious stimuli tracheal intubation induction,C0002771|C0209337|C0030193|C0205100|C0002771|C0871161|C0599946|G0000000|C0234402|C0040578|C0021925|C0205263
